| __timestamp | BeiGene, Ltd. | Intra-Cellular Therapies, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21862000 | 21226345 |
| Thursday, January 1, 2015 | 58250000000 | 87718074 |
| Friday, January 1, 2016 | 98033000 | 93831530 |
| Sunday, January 1, 2017 | 269018000 | 79419009 |
| Monday, January 1, 2018 | 679005000 | 132166913 |
| Tuesday, January 1, 2019 | 927338000 | 89124838 |
| Wednesday, January 1, 2020 | 1294877000 | 65782137 |
| Friday, January 1, 2021 | 1459239000 | 88845513 |
| Saturday, January 1, 2022 | 1640508000 | 134715000 |
| Sunday, January 1, 2023 | 1778594000 | 180142000 |
Unleashing insights
In the ever-evolving landscape of biotechnology, research and development (R&D) expenses are a critical indicator of a company's commitment to innovation. Over the past decade, BeiGene, Ltd. and Intra-Cellular Therapies, Inc. have demonstrated contrasting trajectories in their R&D investments.
From 2014 to 2023, BeiGene's R&D expenses surged by an astounding 8,000%, reflecting its aggressive pursuit of groundbreaking therapies. In contrast, Intra-Cellular Therapies exhibited a more modest growth of approximately 750% in the same period. Notably, BeiGene's R&D spending in 2023 was nearly ten times that of Intra-Cellular Therapies, underscoring its dominant position in the biotech arena.
This divergence highlights the strategic choices each company has made in their quest for innovation, with BeiGene focusing on expansive growth and Intra-Cellular Therapies opting for a more measured approach.
Research and Development Investment: Merck & Co., Inc. vs BeiGene, Ltd.
Vertex Pharmaceuticals Incorporated vs BeiGene, Ltd.: Strategic Focus on R&D Spending
Comparing Innovation Spending: GSK plc and BeiGene, Ltd.
Who Prioritizes Innovation? R&D Spending Compared for BeiGene, Ltd. and Insmed Incorporated
Research and Development: Comparing Key Metrics for BeiGene, Ltd. and Madrigal Pharmaceuticals, Inc.
Research and Development Investment: BeiGene, Ltd. vs Halozyme Therapeutics, Inc.
R&D Spending Showdown: BeiGene, Ltd. vs Opthea Limited
Research and Development Expenses Breakdown: BeiGene, Ltd. vs ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for BeiGene, Ltd. and Supernus Pharmaceuticals, Inc.
Intra-Cellular Therapies, Inc. vs Blueprint Medicines Corporation: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Intra-Cellular Therapies, Inc. vs Sarepta Therapeutics, Inc.
Intra-Cellular Therapies, Inc. or Vericel Corporation: Who Invests More in Innovation?